Redirect Notice
The previous page is sending you to
http://investorstemcell.com/stem-cell-research/stem-cell-therapy-developer-athersys-nasdaqathx-plans-to-begin-the-first-clinical-study-of-its-multistem-technology-in-stroke-patients-by-the-end-of-the-year/
.
If you do not want to visit that page, you can
return to the previous page
.